Combinations of AKT inhibitor compounds and abiraterone, and methods of use
US9346789B2 · kind B2 · utility
2Cited by
41References
21Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 30, 2012 |
| Grant date | May 24, 2016 |
| Priority date | — |
| Expiry date | Mar 30, 2032 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2039/505
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides a combination of a) a compound of Formula (Ia): or a pharmaceutically acceptable salt thereof, and b) abiraterone or a pharmaceutically acceptable salt thereof for the prophylactic or therapeutic treatment of a hyperproliferative disorder, such as cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.